Hasta la próxima

Auto reproducción

The role of chemotherapy in Hodgkin lymphoma

0 vistas • 06/26/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Yago Nieto, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of chemotherapy in Hodgkin lymphoma (HL) treatment, which is typically employed in combination with novel agents such as brentuximab vedotin or checkpoint inhibitors. However, Prof. Nieto highlights that frail patients may require alternative chemotherapy-free approaches. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción